ArticleBiomedicines2024

Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series.

Marilda Mormando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.